New drug aims to tame severe allergies by targeting IgE
Disease control
Not yet recruiting
This early-stage study tests a new medicine called cizutamig in 20 adults with severe allergies, including food allergies. The goal is to see if it safely lowers IgE, a key antibody involved in allergic reactions. Participants will receive the drug and be monitored for side effec…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:56 UTC